BSMA Award

BSMA Award for Supply Chain Management Innovation

The BSMA Award for Supply Chain Management Innovation will be given to the chosen entity from stakeholders of the Biotech industry – Manufacturers, Service Providers, Material Suppliers, Technology Enablers, Academia, Management Consultants, Trade Associations and Governmental Regulators, as approved by the Advisory Board of BSMA. A winner will be adjudged from all stakeholders as deemed meeting standards of excellence by the review committee.

Application Deadline: February 1, 2024

Submit an entry for this prestigious award to (click on the name below):

Devendra Mishra, 818-224-1552


Showcase your innovative project!

Submit a 300-word Case Study to include the nature of the innovation that enhanced the supply chain; objective(s) of the endeavour; strategies and tactics adopted; benefits realized and costs incurred; human, technology and organizational resources deployed; and, governmental compliance requirements met, if applicable. Please identify the Company to be recognized for the award.

Winners will be selected by a prestigious panel of judges and honoured at BSMA’s Annual Conference on March 21, 2024, at the Crowne Plaza Suites, Foster City, CA. Devendra Mishra is the Chairman of the Awards Committee.

BSMA SCM Innovation Award Winners will receive:

  • Recognition at the BSMA 13th Annual Conference
  • A prestigious iconic award
  • Two complimentary full conference passes to BSMA’s 13th Annual Conference, and Networking opportunity with executives and other award-winning colleagues
  • Your innovation story featured in the BSMA press releases and posted on the BSMA website
  • Opportunity for an interview to be published by BSMA


This award recognizes that increasing pace of innovation, regulatory issues, and overall distribution complexities of the industry produce extraordinary supply chain opportunities. Integration of supply chain management with R&D and sales & marketing organizations is the key to fully capturing business opportunities, increasing speed-to-market, and reducing costs. Product introduction is accelerating and there is an increasing level of interest in ways that all parties can work together to optimize the supply chain to support and sustain market demands. Efforts to overcome counterfeiting, potential recalls and patent-expiration as drugs progress through their life-cycle is improving patient safety. Furthermore, collaboration in the end-to-end supply chain of the biotech industry is the key for Jay Forrester’s stated objective to “minimize system-wide cost for supply chain management optimization” to be realized. Consequently, recognizing innovation is deemed critical for the growth of biotech.


Bayer is reimagining its global supply chain for sustainability and is leveraging synergies with industry to advance the “Pharmaceutical Supply Chain Initiative” (PSCI) and the “Together for Sustainability” (TfS) program, the latter co-founded by Bayer. As a result, sustainability assessments and audit results of suppliers are exchanged between the sourcing and supplying organizations to enable allocation of resources more efficiently and to mutually improve sustainability standards. Its global warehousing and transportation network management is emerging to be exemplary for delivery of patientcare.

BeiGene is engaged in developing more affordable and accessible medicines for patients everywhere by building a systems-driven supply chain to support an entrepreneurial team of R&D scientists. “Rational” drug design, in which targets are selected based on their observed role in cancer cell growth and survival, has been a cornerstone of its development efforts. Furthermore, the principles of Inclusion, Diversity, Equity, and Awareness drive the young, global organization where excellence is achieved through collaboration internally and with business partners.

In the post-COVID world, Catalent has provided essential services to its clients in development, clinical study, process and scale-up optimization, and commercialization of drugs.  Its comprehensive clinical supply services and worldwide distribution network, supported the local, regional and global studies to enable faster and more seamless product launches by shifting from foreign to US based CMO’s with multi-modality manufacturing. The scientists, technicians and employees serving 50 depots across 6 continents are committed to driving complex, global change required for healthcare.

(L-R) Devendra Mishra (Executive Director. BSMA), Wahiba Hall (Head Supply Chain Compliance CoE, Divisional PH – Global Export Control Officer, Bayer)

(L-R) Devendra Mishra (Executive Director, BSMA), Rutesh Desai (Sr Manager, Global Supply Chain, Beigene), Bill Coakley (Executive Vice President, Clinical & Commercial Supply Chain Mgmt, BSMA)

(L-R) Devendra Mishra (Executive Director, BSMA), Eric Valentine (Vice President, Clinical Supply Service, Catalent Pharma Solutions), Bill Coakley (Executive Vice President, Clinical & Commercial Supply Chain Mgmt, BSMA)

Prior Awardees will soon be added.  Return to see who received the prestigious BSMA SCM Awards in the past.